Value of Pentraxin3 (PTX3) in Patients with Neovascular Age-related Macular Degeneration

Mehmet AgilliDepartment of Biochemistry, Agri Military Hospital, Agri, Turkey, Correspondence[email protected]

, MD,

Fevzi Nuri AydinDepartment of Biochemistry, Sirnak Military Hospital, Sirnak, Turkey, and

, MD,

Tuncer CayciDepartment of Medical Biochemistry, Gulhane Military Medical Academy, Ankara, Turkey

, MD &

Yasemin Gulcan KurtDepartment of Medical Biochemistry, Gulhane Military Medical Academy, Ankara, Turkey

, MD

"Value of Pentraxin3 (PTX3) in Patients with Neovascular Age-related Macular Degeneration." Ocular Immunology and Inflammation, 24(3), p. 358

Declaration of interest

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Value of Pentraxin3 (PTX3) in Patients with Neovascular Age-related Macular Degeneration

Information for

Open access

Opportunities

Help and information

Value of Pentraxin3 (PTX3) in Patients with Neovascular Age-related Macular Degeneration

Declaration of interest

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature